156 results
Page 5 of 8
8-K
EX-99.1
u7m2u2
17 Dec 14
TG Therapeutics, Inc. Announces Appointment of Kenneth Hoberman to Board of Directors
12:00am
8-K
EX-99.1
216eku9fuerm8
9 Dec 14
Other Events
12:00am
8-K
EX-99.3
i7zydk3hgnlen4e
9 Dec 14
Other Events
12:00am
8-K
EX-99.2
0v1ezgk hkrbdtp0w1p
9 Dec 14
Other Events
12:00am
8-K
EX-99.1
ebakayd6
10 Nov 14
TG Therapeutics, Inc. Announces Third Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
tb0s2
15 Sep 14
Overall Response Rate (ORR) to be the Primary Endpoint to Support Accelerated Approval with Progression-Free Survival (PFS) to Support Full Approval
12:00am
8-K
EX-99.1
r9cc3
21 Jul 14
Other Events
12:00am
8-K
EX-99.1
5nh6tu 5c
21 Jul 14
TG Therapeutics, Inc. Announces Second Quarter 2014 Financial Results and Business Update
12:00am
8-K
EX-99.1
bnyvtvshwo5n5k
30 May 14
TG Therapeutics, Inc. Announces Presentation of Single Agent Data for Both TG-1101 and TGR-1202 in Ongoing Phase I Clinical Studies
12:00am
424B5
7y6ahx 7rrukc
12 Mar 14
Prospectus supplement for primary offering
12:00am